Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder, is no more effective than a placebo, according to a study led by researchers at the San Francisco VA Medical Center.
There was no benefit at all, and there were several adverse side effects, says lead author Thomas Neylan, MD, medical director of the PTSD treatment program at SFVAMC.
People with symptoms of PTSD should probably stay away from this drug and others of its type.
The study appears in the December 1, 2006 issue of the American Journal of Psychiatry.
Guanfacine belongs to a class of medications known as alpha-2 agonists, which lower the brain's supply of the neurotransmitter norepinephrine.
Neurotransmitters are chemicals that transmit electrical signals between nerve cells. They are responsible for many aspects of behavior.
Norepinephrine is released in the brain during states of excited arousal, and PTSD is associated with that state -- patients startle easily, have trouble sleeping, and are hypervigilant and anxious, explains Neylan, who is also an associate professor of psychiatry at the University of California, San Francisco.
Guanfacine and clonidine, another alpha-2 agonist, are commonly prescribed for PTSD symptoms. There are at least 20 peer-reviewed articles published in the field of PTSD that recommend drugs which lower norepinephrine, Neylan says. However, ours was the first randomized, controlled study of alpha-2 agonists for symptoms of PTSD.
The double-blind study compared the effects of guanfacine and an identical looking placebo pill on 63 male and female veterans at four VA medical centers in California and Hawaii. Twenty-nine participants were randomly assigned to take weekly doses of the drug, and 34 were assigned the placebo, for eight weeks.
At the end of the study, the effect of guanfacine on PTSD symptoms was zero, and there were no differences between men and women or older versus younger veterans.
In addition, the subjects who took guanfacine had significantly more somnolence, lightheadedness, and dry mouth than those who took placebo.
The study authors conclude, These results do not support the use of alpha 2 agonists in veterans with chronic PTSD.
Neylan speculates that instead of lowering the overall level of norepinephrine, a more effective approach might be to inhibit the ability of brain cells to respond to the neurotransmitter.
He notes that this is the action of prazosin, a blood pressure medication that has been found by other researchers to decrease the incidence of nightmares in combat veterans with PTSD.
Study co-authors were Maryann Lenoci, MA, and Kristin W. Franklin, PhD, of SFVAMC; Thomas J.
Metzler, MA, of UCSF and SFVAMC; Clare Henn-Haase, PsyD, of SFVAMC; Robert W. Hierholzer, MD, of UCSF and Fresno VA Medical Center, Fresno, Calif.; Steven E.
Lindley, MD, PhD, of Stanford University and Palo Alto VA Medical Center, Palo Alto, Calif.; Christian Otte, MD, of UCSF, SFVAMC, and University Hospital Hamburg-Eppendorf, Germany; Frank B. Schoenfeld, MD, of UCSF and SFVAMC; Jerome A.
Yesavage, MD, of Stanford University and PAVAMC; and Charles R. Marmar, MD, of SFVAMC and UCSF.
The study was funded by support from the Department of Veterans Affairs.
Note: This story has been adapted from a news release issued by University of California - San Francisco.
(April 9, 2004) -- A study published in the April issue of The Journal of Pediatrics shows that the occurrence of Post-traumatic Stress Disorder (PTSD) increases significantly in school-age children who experience ..
.
(March 27, 1998) -- People with lower intelligence before a traumatic experience are more likely to develop posttraumatic stress disorder (PTSD) symptoms, according to the first study to identify a cognitive risk factor ..
.
(November 7, 2006) -- Children who are more intelligent at age 6 may be less likely to experience trauma by age 17 and if they do, may be less likely to develop post-traumatic stress disorder, according to a report in the ..
.
(January 21, 2002) -- For the first time, researchers here have found an effective therapy that can alleviate the fatigue often accompanying multiple sclerosis. Many therapies have been developed to treat symptoms of .
..
(November 20, 2006) -- Males experience more traumatic events on average than do females, yet females are more likely to meet diagnostic criteria for post-traumatic stress disorder, according to a review of 25 years of .
..
(January 22, 2004) -- High levels of estrogen may enhance the brain's response to stress, making women more vulnerable to mental illnesses such as depression and post-traumatic stress disorder (PTSD), according to a Yale .
..
(September 26, 2005) -- Heart attack patients, and most likely those with other forms of heart disease, run an increased risk of developing post-traumatic stress disorder, says a new research review done in Denmark and the .
..
(February 24, 2003) -- NIDA-supported researchers from Yale University Transdisciplinary Tobacco Use Research Center (TTURC) have found more evidence that monoamine oxidase-B (MAO-B) inhibitors may be an effective .
..
(April 20, 2005) -- Cognitive therapy, when provided by an experienced therapist, may be as effective as antidepressant medications in the initial treatment of moderate to severe major depression, according to an .
..
(November 26, 1997) -- Veterans of heavy combat in Vietnam who were diagnosed with post-traumatic stress disorder (PTSD) are significantly more likely to have a host of both chronic and infectious diseases as long as 20 .
..
-- The double blind method is an important part of the scientific method, used to prevent research outcomes from being 'influenced' by the placebo effect or observer bias.
Blinded research is an ...
-- Psychological trauma is a type of damage to the psyche that occurs as a result of a traumatic event. A traumatic event involves a singular experience or enduring event or events that completely ..
.
-- An antidepressant is a medication designed to treat or alleviate the symptoms of clinical depression. Some antidepressants, notably the tricyclics, are commonly used off-label in the treatment of .
..
-- The most commonly performed clinical trials evaluate new drugs, medical devices, biologics, or other interventions to patients in strictly scientifically controlled settings, and are required for .
..
-- Psychopharmacology is the study of drug-induced changes in mood, thinking, and behavior.
These drugs may originate from natural sources such as plants and animals, or from artificial sources such as ...
-- Post-traumatic stress disorder (PTSD) is a term for certain psychological consequences of exposure to, or confrontation with, stressful experiences that the person experiences as highly traumatic. ..
.
-- Drug addiction, or substance dependence is the compulsive use of psychoactive drugs, to the point where the user has no effective choice but to continue use. Drug addiction has two components: .
..
-- The placebo effect, also known as non-specific effects and the subject-expectancy effect, is the phenomenon that a patient's symptoms can be alleviated by an otherwise ineffective treatment, since .
..
-- Hormone replacement therapy (HRT) is a system of medical treatment for perimenopausal and postmenopausal women, based on the assumption that it may prevent discomfort and health problems caused by .
..
The best-selling nursing drug handbook for 26 years is now in its fully updated 2006 edition. Organized by therapeutic class, Nursing2006 Drug Handbook provides quick access to current, accurate .
..
For more than 50 years, The Harriet Lane Handbook has been the pediatrician s reference of choice and for good reason. Its unsurpassed diagnostic and management guidance, recommended tests, .
..
Help yourself to a pain-free back. This easy-to-follow book presents over 80 pages of education and clinically-proven exercises.
The simple and effective self-help exercises in Robin McKenzie's Treat ...
Pain KillerOxyContin, a potent painkiller containing opium-derived oxycodone as its key active ingredient, was first sold in 1996 as a treatment for cancer patients and other chronic pain sufferers.
...
This perennial best seller has set the standard for dosage calculations.
This formula method text contains more practice questions than any competitor; full color labels; equipment; pediatric ...
What causes chronic, debilitating back pain, one of the most common--and expensive to treat--ailments in the world?
According to Robin McKenzie, a New Zealand physiotherapist for over 40 years and ...
The most impressive idea to emerge from the recent World Economic Summit in Davos, Switzerland: a new approach to identifying and managing the world's twenty most pressing problems.
In this age of ...
The Chemist s Companion A Handbook of Practical Data, Techniques, and References Arnold J.
Gordon and Richard A. Ford Contents Properties of Molecular Systems Properties of Solvents and Common ..
.
The essential emergency medicine reference! Covers the gamut of emergency medicine practice in brief, clinically focused chapters. New to this edition are chapters on bioterroism and weapons of .
..
News RSS